IN2012DN01979A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01979A
IN2012DN01979A IN1979DEN2012A IN2012DN01979A IN 2012DN01979 A IN2012DN01979 A IN 2012DN01979A IN 1979DEN2012 A IN1979DEN2012 A IN 1979DEN2012A IN 2012DN01979 A IN2012DN01979 A IN 2012DN01979A
Authority
IN
India
Prior art keywords
prognosis
diagnosis
compositions
cervical
determining
Prior art date
Application number
Other languages
English (en)
Inventor
Wenyan Qin
Peng Dong
Tuo Deng
Cailing Ma
Keith Mitchelson
Hao Wen
Jing Cheng
Original Assignee
Capitalbio Corp
Univ Tsinghua
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capitalbio Corp, Univ Tsinghua filed Critical Capitalbio Corp
Publication of IN2012DN01979A publication Critical patent/IN2012DN01979A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN1979DEN2012 2009-08-07 2010-08-06 IN2012DN01979A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2009/000895 WO2011014980A1 (en) 2009-08-07 2009-08-07 Methods and compositions diagnosing cervical cancer and cervical dysplasia, guidding subsequent treatment, determining prognosis, and improving patient survival
PCT/CN2010/001202 WO2011015040A1 (zh) 2009-08-07 2010-08-06 用于宮颈上皮內瘤样病变和宮致癌的诊断和预后的方法与組合物

Publications (1)

Publication Number Publication Date
IN2012DN01979A true IN2012DN01979A (ja) 2015-08-21

Family

ID=43543859

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1979DEN2012 IN2012DN01979A (ja) 2009-08-07 2010-08-06

Country Status (4)

Country Link
US (1) US8957039B2 (ja)
EP (1) EP2463381A4 (ja)
IN (1) IN2012DN01979A (ja)
WO (2) WO2011014980A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106939333B (zh) * 2016-05-30 2018-07-03 山西医科大学第二医院 miRNA标志物在制备筛查叶酸缺乏群体的宫颈上皮内瘤变试剂中的应用
CN110290794A (zh) 2016-11-01 2019-09-27 纽约州州立大学研究基金会 5-卤代尿嘧啶修饰的微rna及其在癌症治疗中的用途
US11236337B2 (en) 2016-11-01 2022-02-01 The Research Foundation For The State University Of New York 5-halouracil-modified microRNAs and their use in the treatment of cancer
CN106755378B (zh) * 2016-12-13 2021-05-07 北京林业大学 一种检测miRNA来源的方法
CN107354227A (zh) * 2017-09-06 2017-11-17 苏州吉玛基因股份有限公司 microRNA探针一步法实时荧光定量PCR检测方法
CN111455064B (zh) * 2020-04-14 2022-06-28 汕头大学 miRNA-sc-miR-145在鱼类LC-PUFA合成的应用
KR102534199B1 (ko) * 2020-11-11 2023-05-19 아주대학교산학협력단 자궁경부암의 조기 진행 진단용 바이오 마커 및 이의 용도
KR102534200B1 (ko) * 2020-11-11 2023-05-19 아주대학교산학협력단 자궁경부암의 전이 진단용 바이오 마커 및 이의 용도
CN115040530A (zh) * 2022-04-20 2022-09-13 大连大学 hsa-miR-320a在抑制肿瘤细胞迁移药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005056797A1 (en) * 2003-12-15 2005-06-23 Kye-Seong Kim Novel mirna molecules isolated from human embryonic stem cell
US20050277139A1 (en) * 2004-04-26 2005-12-15 Itzhak Bentwich Methods and apparatus for the detection and validation of microRNAs
EP2471922A1 (en) 2004-05-28 2012-07-04 Asuragen, Inc. Methods and compositions involving microRNA
US20080076674A1 (en) * 2006-07-06 2008-03-27 Thomas Litman Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer
WO2008061537A2 (en) * 2006-11-23 2008-05-29 Querdenker Aps Oligonucleotides for modulating target rna activity
WO2008095096A2 (en) 2007-01-31 2008-08-07 Immune Disease Institute Let-7 microrna and mimetics thereof as therapeutics for cancer
US8361714B2 (en) * 2007-09-14 2013-01-29 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof

Also Published As

Publication number Publication date
US8957039B2 (en) 2015-02-17
US20120202872A1 (en) 2012-08-09
WO2011014980A1 (en) 2011-02-10
EP2463381A4 (en) 2013-01-02
EP2463381A1 (en) 2012-06-13
WO2011015040A1 (zh) 2011-02-10

Similar Documents

Publication Publication Date Title
IN2012DN01979A (ja)
AU2016204376A1 (en) MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer
WO2010099161A8 (en) Micrornas in never-smokers and related materials and methods
WO2010102195A3 (en) Annexin a11 and associated genes as biomarkers for cancer
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
PH12013502230A1 (en) Multispecific antibodies
TN2009000521A1 (en) Rnai inhibition of alpha-enac expression
TN2011000673A1 (en) Bace inhibitors
EP3683320A3 (en) Mirna fingerprint in the diagnosis of lung cancer
EP2323677A4 (en) MICRO-RNA BASED COMPOSITIONS AND METHODS OF DIAGNOSIS, FORECAST AND TREATMENT OF MULTIPLE MYELOMA
EP2257647A4 (en) MICRO-RNA-BASED PROCEDURES AND COMPOSITIONS FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF GAS CANCER
MX2010006576A (es) Composiciones y metodos para producir isopreno.
MY179933A (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereof
MX338884B (es) Composiciones y metodos que comprenden variantes de proteasa.
IN2012DN03883A (ja)
WO2012083969A3 (en) Microrna for diagnosis of pancreatic cancer
MX2011010012A (es) NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS.
ZA201300519B (en) Novel antibody for the diagnosis and/or prognosis of cancer
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
WO2011021177A3 (en) Compositions and methods for prognosis and treatment of prostate cancer
EP2576575A4 (en) PROSTAGLANDIN-BISPHOSPHONATE CONJUGATE COMPOUNDS, THEIR METHODS OF MANUFACTURE AND USES THEREOF
IN2012DN01379A (ja)
WO2011044513A9 (en) Diagnostic and prognostic markers for cancer
TW201144809A (en) Marker for gastric cancer and method for detecting gastric cancer
IN2012DN05142A (ja)